August 12, 2019 C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting
August 7, 2019 Funded by FDA, C-Path and NORD to Launch Rare Disease Data and Analytics Platform The collaborative project between the organizations will kick off at a launch meeting in September and will aim to r
July 4, 2019 Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol
July 2, 2019 C-Path Taps Medical Science Operations Executive Kristen Swingle as Chief Operating Officer TUCSON, Ariz., July 2, 2019 — The Critical Path Institute (C-Path) is pleased to announce that after an extensive
June 25, 2019 Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials
June 19, 2019 The Critical Path for Parkinson’s consortium announces C-Path’s Data Sharing Pioneer Award recipients The Critical Path for Parkinson’s consortium (CPP) is pleased to announce the following recipients as the first to receive C
June 11, 2019 Scientific and Regulatory Considerations for the Analytical Validation of Assays Used in the Qualification of Biomarkers in Biological Matrices
June 11, 2019 C-Path’s PSTC Releases Points to Consider Outlining Recommendations for Analytical Validation of Assays Used in Qualifying Biomarkers The document serves as a guide to the analysis of biomarkers in drug development TUCSON, Ariz., June 11, 2019 — The Critical Pat
June 3, 2019 Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan